ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

BMRA Biomerica Inc

0.577
0.017 (3.04%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 22,606
Bid Price 0.5503
Ask Price 0.80
News -
Day High 0.579

Low
0.50

52 Week Range

High
2.13

Day Low 0.5565
Share Name Share Symbol Market Stock Type
Biomerica Inc BMRA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.017 3.04% 0.577 23:00:10
Open Price Low Price High Price Close Price Previous Close
0.5601 0.5565 0.579 0.577 0.56
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
193 22,606 US$ 0.5651257 US$ 12,775 - 0.50 - 2.13
Last Trade Type Quantity Price Currency
15:00:00 88 US$ 0.57 USD

Biomerica Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
9.76M 16.82M - 5.34M -7.14M -0.42 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Biomerica News

Date Time Source News Article
5/13/202407:19GlobeNewswire Inc.Biomerica Announces inFoods® IBS Pilot Launch with Prominent..
5/10/202416:20Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
5/10/202416:15Edgar (US Regulatory)Form 8-K - Current report
4/29/202407:19GlobeNewswire Inc.Biomerica and Leading UAE Healthcare Company Forge a Path to..
4/15/202406:47GlobeNewswire Inc.Biomerica provides update on inFoods® IBS expansion
4/12/202418:23GlobeNewswire Inc.Biomerica Reports Third Quarter 2024 Financial Results
3/28/202407:19GlobeNewswire Inc.Biomerica InFoods IBS Data to be Presented at the Upcoming..
2/21/202407:19GlobeNewswire Inc.Diagnostics Industry Leader Gary Huff Appointed to Biomerica..
2/14/202408:00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
2/09/202414:06Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial..
1/23/202407:19GlobeNewswire Inc.Diagnostics Industry Leader Jack Kenny Appointed as Chairman..
1/16/202407:19GlobeNewswire Inc.Biomerica Reports Second Quarter 2024 Financial Results
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BMRA Message Board. Create One! See More Posts on BMRA Message Board See More Message Board Posts

Historical BMRA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.5650.59990.530.564954553,6170.0122.12%
1 Month0.61610.6870.530.611560751,581-0.0391-6.35%
3 Months1.011.040.500.5987379249,847-0.433-42.87%
6 Months0.972.130.501.43729,769-0.393-40.52%
1 Year1.5052.130.501.44434,679-0.928-61.66%
3 Years4.097.380.503.89385,473-3.51-85.89%
5 Years2.3423.390.505.82411,808-1.76-75.34%

Biomerica Description

Biomerica Inc is engaged in the development, manufacturing, and marketing medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. Majority of the company's revenue is earned from the Europe market.

Your Recent History

Delayed Upgrade Clock